C.R. Jackson
Biotech, healthcare, value, research analyst

Will Coronado Biosciences Revolutionize Medicine?

Burlington, Massachusetts-based Coronado Biosciences, Inc., (CNDO), is a clinical stage biopharmaceutical company that develops immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. Coronado was founded in 2006.

This 230M market cap company's lead pharmaceutical product candidates are:

  • TSO or CNDO-201, a biologic comprising Trichuris suis ovathe, the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn's disease, ulcerative colitis, multiple sclerosis, autism, psoriasis, type 1 diabetes, and rheumatoid arthritis; and
  • CNDO-109, a biologic that activates the immune system's natural killer (NASDAQ:NK) cells to target and kill cancer cells, for the treatment of acute myeloid leukemia (AML) and myeloid myeloma.


TSO (Trichuris suis ova or...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details